Cutaneous Melanoma Active Not Recruiting Phase 2 Trials for Ascorbic acid (DB00126)

IndicationStatusPhase
DBCOND0040978 (Cutaneous Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02129075CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV MelanomaTreatment